Piñero A, Reus M, Illana J, Durán I, Martínez-Barba E, Canteras M, Parrilla P
Department of General Surgery, Virgen de la Arrixaca University Hospital, El Palmar, Murcia, Spain.
Breast. 2003 Aug;12(4):258-63. doi: 10.1016/s0960-9776(03)00103-6.
This study was designed to find whether there are any differences between benign and malignant palpable breast lesions as they are seen on grey-scale and colour-Doppler and on power-Doppler sonography; to determine which variables for each technique are most helpful in distinguishing any such differences; and to see whether the use of an echo-enhancing agent gives better results in the differential diagnosis. Forty-five palpable breast lesions (16 benign and 29 malignant) were evaluated in a preoperative study using grey-scale sonography, colour-Doppler sonography and power-Doppler sonography before and after administration of an echo-enhancing agent (Levovist). We reached the following conclusions: (1) In the grey-scale ultrasound study of palpable breast lesions the presence of microcalcifications, acoustic shadowing and non-well-defined margins are related to malignancy. (2) Colour- and power-Doppler sonography may help in the differential diagnosis. (3) The use of an echo enhancer (Levovist) accentuates these differences and enables them to be noted in other variables, such as pulsatility index, nodule-to-vascularity ratio and number of poles.
本研究旨在探讨在灰阶超声、彩色多普勒超声及能量多普勒超声下,可触及的乳腺良恶性病变之间是否存在差异;确定每种技术的哪些变量最有助于区分这些差异;以及观察使用超声造影剂是否能在鉴别诊断中取得更好的结果。在一项术前研究中,对45个可触及的乳腺病变(16个良性和29个恶性)在使用超声造影剂(声诺维)前后分别进行灰阶超声、彩色多普勒超声及能量多普勒超声检查。我们得出以下结论:(1)在对可触及乳腺病变的灰阶超声检查中,微钙化、声影及边界不清与恶性病变有关。(2)彩色及能量多普勒超声有助于鉴别诊断。(3)使用超声造影剂(声诺维)可突出这些差异,并使在其他变量中也能观察到这些差异,如搏动指数、结节与血管比值及极数。